Company Stratec SE

Equities

SBS

DE000STRA555

Advanced Medical Equipment & Technology

Market Closed - Xetra 16:35:16 30/04/2024 BST After market 19:23:14
43.3 EUR +0.81% Intraday chart for Stratec SE 43.22 -0.17%

Business Summary

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

Number of employees: 1,473

Sales per Business

EUR in Million2022Weight2023Weight Delta
Analyzer Systems
43.5 %
- - 114 43.5 % -
Service Parts and Consumables
36.7 %
- - 96 36.7 % -
Development and Services
19.0 %
- - 50 19.0 % -
Other
0.8 %
- - 2 0.8 % -

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
35.5 %
79 28.6 % 93 35.5 % +18.33%
European Union
35.2 %
110 40.0 % 92 35.2 % -16.12%
Germany
19.7 %
57 20.7 % 52 19.7 % -9.26%
Other
9.6 %
29 10.7 % 25 9.6 % -14.17%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 28/02/98
Director of Finance/CFO 56 30/04/98
Investor Relations Contact - -
Sales & Marketing 51 31/12/22
Corporate Officer/Principal 56 31/08/98

Members of the board

Members of the board TitleAgeSince
Director/Board Member 57 28/05/19
Chairman 66 19/05/22
Director/Board Member 70 20/07/20
Director/Board Member 57 09/06/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,157,841 7,225,937 ( 59.43 %) 1,899 ( 0.0156 %) 59.43 %

Shareholders

NameEquities%Valuation
Allianz Global Investors GmbH (France)
5.803 %
705,538 5.803 % 31 M €
Invesco Advisers, Inc.
5.016 %
609,879 5.016 % 26 M €
Juno Investment Partners
3.081 %
374,586 3.081 % 16 M €
Threadneedle Asset Management Ltd.
2.848 %
346,292 2.848 % 15 M €
Amundi Asset Management SA (Investment Management)
1.214 %
147,536 1.214 % 6 M €
Tocqueville Finance SA
1.121 %
136,325 1.121 % 6 M €
BNP Paribas Asset Management Belgium SA
0.7365 %
89,537 0.7365 % 4 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.7247 %
88,105 0.7247 % 4 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.6093 %
74,075 0.6093 % 3 M €
Oddo BHF Asset Management GmbH
0.3866 %
47,000 0.3866 % 2 M €

Company contact information

STRATEC SE

Gewerbestrasse 37

75217, Birkenfeld

+49 7082 7916 0

http://www.stratec.com
address Stratec SE(SBS)

Group companies

NameCategory and Sector
Stratec Biomedical Switzerland AG
Financial Conglomerates
STRATEC Services AG
Investment Managers